跳至主要内容
临床试验/ISRCTN17375500
ISRCTN17375500已完成未知

Prevention of delirium in intensive care using low dose risperidone prophylaxis: a randomised placebo controlled trial (PREDELIC trial): a pilot study

Vellore Christian Medical College Foundation0 个研究点目标入组 45 人开始时间: 2021年1月19日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Adults (18>years old) admitted into the medical intensive care unit

排除标准

  • 1. No informed consent obtained
  • 2. Neurological disease (including post-cardiopulmonary resuscitation patients)
  • 3. Coma due to drug overdose
  • 4. Alcohol withdrawal syndrome
  • 5. Antipsychotic therapy over the last 30 days
  • 6. Pregnancy/breast feeding
  • 7. Documented delirium prior to ICU admission
  • 8. Difficulty in CAM-ICU ssessment (serious auditory or visual disorders, severely mentally disabled; serious receptive aphasia)
  • 9. Predicted ICU-stay less than one day
  • 10. Moribund and not expected to survive two days
  • 11. Known allergy to Risperidone
  • 12. Severe haemodynamic instability (vasopressor dose/inotrope dose>20mcg/min)
  • 13. Liver failure (Child-Pugh stage B or C)
  • 14. Renal failure (Stage 3 KDIGO or above)

研究者

发起方
Vellore Christian Medical College Foundation

相似试验